Bundamedik Tbk PT (BMHS) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, Bundamedik Tbk PT (BMHS) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp199.64 Billion ≈ $11.70 Million USD) by net assets (Rp2.39 Trillion ≈ $140.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Bundamedik Tbk PT for the company's overall valuation and market capitalisation.

Bundamedik Tbk PT - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Bundamedik Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bundamedik Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bundamedik Tbk PT ranked by their cash flow conversion efficiency. Explore Bundamedik Tbk PT cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Kluang Rubber Company Malaya
KLSE:2453
-0.001x
SANTA ANA GLOBAL ENTERPRISES, S
MC:STNA
N/A
Jeil Pharmaceutical Co Ltd
KO:271980
-0.037x
Rentokil Initial PLC
LSE:RTO
0.077x
Wieson Technologies Co Ltd
TWO:6272
0.046x
Kervan Gıda Sanayi Ve Ticaret As
IS:KRVGD
-0.001x
Maiden Holdings Ltd
F:4OWA
-0.562x
Oneview Healthcare Plc
AU:ONE
-1.027x

Annual Cash Flow Conversion Efficiency for Bundamedik Tbk PT (2018–2025)

The table below shows the annual cash flow conversion efficiency of Bundamedik Tbk PT from 2018 to 2025. View BMHS share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp2.39 Trillion
≈ $140.31 Million
Rp250.62 Billion
≈ $14.69 Million
0.105x +561.56%
2024-12-31 Rp2.15 Trillion
≈ $125.85 Million
Rp33.98 Billion
≈ $1.99 Million
0.016x -44.64%
2023-12-31 Rp1.80 Trillion
≈ $105.47 Million
Rp51.44 Billion
≈ $3.01 Million
0.029x -78.24%
2022-12-31 Rp1.81 Trillion
≈ $105.96 Million
Rp237.47 Billion
≈ $13.91 Million
0.131x -36.61%
2021-12-31 Rp1.69 Trillion
≈ $98.84 Million
Rp349.44 Billion
≈ $20.48 Million
0.207x +14.24%
2020-12-31 Rp1.05 Trillion
≈ $61.51 Million
Rp190.36 Billion
≈ $11.15 Million
0.181x +34.54%
2019-12-31 Rp665.59 Billion
≈ $39.00 Million
Rp89.72 Billion
≈ $5.26 Million
0.135x +63.82%
2018-12-31 Rp532.23 Billion
≈ $31.19 Million
Rp43.79 Billion
≈ $2.57 Million
0.082x --

About Bundamedik Tbk PT

JK:BMHS Indonesia Medical Care Facilities
Market Cap
$99.82 Million
Rp1.70 Trillion IDR
Market Cap Rank
#19298 Global
#340 in Indonesia
Share Price
Rp198.00
Change (1 day)
-0.50%
52-Week Range
Rp147.00 - Rp226.00
All Time High
Rp1133.21
About

PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides ferti… Read more